Clinical Trials Browser

Phase 2 × Neoplasms, Plasma Cell × Interleukin 1 Receptor Antagonist Protein × Clear all

NCT00635154 2018-06-07

Anakinra With or Without Dexamethasone in Treating Patients With Smoldering or Indolent Multiple Myeloma

Phase 2 Completed

55 enrolled 14 charts

Multiple Myeloma, Neoplasms, Plasma Cell